UY33097A - DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USES - Google Patents
DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USESInfo
- Publication number
- UY33097A UY33097A UY0001033097A UY33097A UY33097A UY 33097 A UY33097 A UY 33097A UY 0001033097 A UY0001033097 A UY 0001033097A UY 33097 A UY33097 A UY 33097A UY 33097 A UY33097 A UY 33097A
- Authority
- UY
- Uruguay
- Prior art keywords
- ureidoarilo
- disustituidos
- pirazol
- derivatives
- therapeutic uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos de fórmula (I): donde R1, R2, R3, Ar, L, X yQ son tal como se han definido aquí y son útiles para el tratamiento o profiláxis de infecciones virales, especialmente infecciones por el virus de la gripe.Compounds of formula (I): where R1, R2, R3, Ar, L, X and Q are as defined herein and are useful for the treatment or prophylaxis of viral infections, especially influenza virus infections.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0921731.6A GB0921731D0 (en) | 2009-12-11 | 2009-12-11 | Theraputic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33097A true UY33097A (en) | 2011-06-30 |
Family
ID=41666983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033097A UY33097A (en) | 2009-12-11 | 2010-12-10 | DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USES |
Country Status (4)
Country | Link |
---|---|
GB (1) | GB0921731D0 (en) |
TW (1) | TW201130813A (en) |
UY (1) | UY33097A (en) |
WO (1) | WO2011070368A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009077766A1 (en) | 2007-12-19 | 2009-06-25 | Cancer Research Technology Limited | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
ES2469367T3 (en) | 2010-02-01 | 2014-06-18 | Cancer Research Technology Limited | 1- (5-Tert-Butyl-2-phenyl-2H-pyrazol-3-yl) -3- [2-fluoro-4- (1-methyl-2-oxo-2,3-dihydro-1H-imidazo [ 4,5-b] pyridin-7-yloxy) -phenyl] -urea and related compounds and their use in therapy |
WO2011158044A2 (en) | 2010-06-17 | 2011-12-22 | Respivert Limited | Respiratory formulations and compounds for use therein |
GB201010196D0 (en) * | 2010-06-17 | 2010-07-21 | Respivert Ltd | Methods |
GB201010193D0 (en) * | 2010-06-17 | 2010-07-21 | Respivert Ltd | Medicinal use |
PL2763984T3 (en) | 2011-10-03 | 2016-10-31 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors | |
EP2578582A1 (en) * | 2011-10-03 | 2013-04-10 | Respivert Limited | 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors |
CN103974953B (en) | 2011-12-09 | 2016-06-29 | 奇斯药制品公司 | Inhibitors of kinases |
KR101994381B1 (en) | 2011-12-09 | 2019-06-28 | 키에시 파르마슈티시 엣스. 피. 에이. | Kinase inhibitors |
GB201214750D0 (en) | 2012-08-17 | 2012-10-03 | Respivert Ltd | Compounds |
WO2014033447A2 (en) | 2012-08-29 | 2014-03-06 | Respivert Limited | Kinase inhibitors |
GB201215357D0 (en) | 2012-08-29 | 2012-10-10 | Respivert Ltd | Compounds |
WO2014033446A1 (en) | 2012-08-29 | 2014-03-06 | Respivert Limited | Kinase inhibitors |
US9783556B2 (en) | 2012-08-29 | 2017-10-10 | Respivert Limited | Kinase inhibitors |
US9732063B2 (en) | 2012-11-16 | 2017-08-15 | Respivert Limited | Kinase inhibitors |
US20160016934A1 (en) | 2013-03-14 | 2016-01-21 | Respivert Limited | Kinase inhibitors |
WO2014162121A1 (en) | 2013-04-02 | 2014-10-09 | Topivert Pharma Limited | Kinase inhibitors based upon n-alkyl pyrazoles |
CN105246884B (en) | 2013-04-02 | 2018-05-22 | 瑞斯比维特有限公司 | Urea derivative as kinase inhibitor |
GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
CA2934199A1 (en) | 2013-12-20 | 2015-06-25 | Respivert Limited | Urea derivatives useful as kinase inhibitors |
TWI751099B (en) | 2014-02-14 | 2022-01-01 | 英商瑞斯比維特有限公司 | Pyrazolyl ureas ask kinase inhibitors, pharmaceutical compositions comprising the same and use thereof |
MA40775A (en) | 2014-10-01 | 2017-08-08 | Respivert Ltd | 4- (4- (4-PHENYLUREIDO-NAPHTALÉN -1-YL) OXY-PYRIDIN-2-YL) AMINO-BENZOIC ACID USED AS A KINASE P38 INHIBITOR |
CN109071505B (en) | 2016-04-06 | 2021-11-16 | 奥苏拉收购有限公司 | Kinase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
US7041669B2 (en) * | 2002-02-25 | 2006-05-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
BRPI0611744B8 (en) | 2005-06-20 | 2021-05-25 | Janssen R & D Ireland | Substituted heterocyclylaminoalkyl benzimidazoles, their preparation process and pharmaceutical composition |
JP5236499B2 (en) | 2006-01-27 | 2013-07-17 | アレイ バイオファーマ、インコーポレイテッド | Glucokinase activator |
PL1979355T3 (en) | 2006-01-30 | 2011-04-29 | Irm Llc | Spiro imidazole derivatives as ppar modulators |
WO2007096764A2 (en) | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
KR20110094130A (en) * | 2008-12-11 | 2011-08-19 | 레스피버트 리미티드 | P38 map kinase inhibitors |
-
2009
- 2009-12-11 GB GBGB0921731.6A patent/GB0921731D0/en not_active Ceased
-
2010
- 2010-12-10 WO PCT/GB2010/052066 patent/WO2011070368A1/en active Application Filing
- 2010-12-10 UY UY0001033097A patent/UY33097A/en unknown
- 2010-12-10 TW TW099143134A patent/TW201130813A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011070368A1 (en) | 2011-06-16 |
TW201130813A (en) | 2011-09-16 |
GB0921731D0 (en) | 2010-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33097A (en) | DERIVATIVES OF (1h-PIRAZOL-5-IL) UREIDOARILO 1,3-DISUSTITUIDOS AND ITS THERAPEUTIC USES | |
ECSP17084267A (en) | PYRAZOLO[1,5—A]PYRIMIDINES AS ANTIVIRAL AGENTS | |
CL2019000271A1 (en) | Hcv polymerase inhibitors (divisional application 201600493) | |
CY1124469T1 (en) | PYRIMIDINE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF GENEROUS INFECTIONS | |
ECSP11011310A (en) | CARBA ANALOGS - NUCLEOSIDE FOR ANTIVIRAL TREATMENT | |
CL2017001426A1 (en) | New compounds of 3-substituted 5-amino-6h-thiazolo [4,5-d] pyrimidin-2,7-dione for the treatment and prophylaxis of viral infections. | |
CY1117200T1 (en) | Benzylamine derivatives as suspensions | |
PH12015500347A1 (en) | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
CA2807584C (en) | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment | |
ECSP099319A (en) | THIOPHEN ANALOGS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | |
UA116083C2 (en) | Purine derivatives for the treatment of viral infections | |
ECSP10010210A (en) | ANTIVIRAL NUCLEOSID COMPOUNDS | |
CO6561783A2 (en) | FLAVIVIRIDAE VIRUS INHIBITORS | |
HK1166788A1 (en) | ||
UY32462A (en) | NEW BIFENYLL DERIVATIVES FOR HEPATITIS C 644 VIRUS INFECTION TREATMENT | |
CO6680667A2 (en) | Ester derivatives of cyclic boronic acid and its therapeutic uses | |
ECSP10010609A (en) | CARBA-NUCLEOSIDOS ANALOGOS 1 '- REPLACED FOR ANTIVIRAL TREATMENT | |
NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
IN2012DN01855A (en) | ||
ECSP11011389A (en) | ORGANIC COMPOUNDS AND THEIR USES | |
MX2012006026A (en) | 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections. | |
ECSP15035530A (en) | TETRAYCLIC COMPOUNDS SUBSTITUTED WITH HETEROCICLO AND METHODS OF USE OF THE SAME FOR THE TREATMENT OF VIRAL DISEASES | |
CY1118399T1 (en) | Benzofuran compounds for viral infections c treatment | |
CL2008002291A1 (en) | Compounds derived from 4-fluoro-benzoic acid, hcv polymerase inhibitors, pharmaceutical composition, pharmaceutical kit and their use for the treatment of a viral infection by hepatitis c. | |
MX2016001855A (en) | Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection. |